Search
    Skip to main content
    Advertisement

    Genentech

    1. Business
    2. Biotech
    3. Genentech
    Biocon settles US patent dispute with Roche's Genentech, eyes 2027 Perjeta biosimilar launch The Times of India21:53Roche Pharma Biotech
    Biocon gets launch clarity for breast cancer biosimilar after Genentech deal The Hindu Business Line12:08Roche Pharma Biotech
    FDA approves atezolizumab combination for stage III colon cancer with deficient DNA mismatch repair News-Medical.Net14:20FDA Colorectal Cancer Cancer Treatment
    SOUTH SAN FRANCISCO's Alector lands $100M Genentech deal for brain drug Hoodline16:53Alector Biotechnology Pharma
    Alector stock rises 26% after Genentech licensing deal RTT News11:49Alector Biotechnology Pharma
    Genentech's giredestrant posts positive phase 3 data ahead of November, December FDA dates RTT News04:23Breast Cancer FDA Pharma

    Latest News

    Yesterday
    Taking The Pulse, A Health Care and Life Sciences Video Podcast | Episode 291: Genentech at 50 and the Future of… JD Supra11:13 16-Oct-26
    FDA Approves Genentech’s Enspryng, a First-in-Class Il-6R Inhibitor, as the First and Only… Business Wire (Press Release)01:03 16-Oct-26
    In the last 7 days
    Genentech Wins Judge's OK Of $18M Novartis Award Law36022:31 14-Oct-26
    Biocon settles US patent dispute with Roche's Genentech, eyes 2027 Perjeta biosimilar launch The Times of India21:53 14-Oct-26
    Genentech Drops Lawsuit Against Biocon Over Perjeta Biosimilar Bloomberg Law15:22 14-Oct-26
    Biocon gets launch clarity for breast cancer biosimilar after Genentech deal The Hindu Business Line12:08 14-Oct-26
    Biocon inks global patent settlement pact with Genentech for breast cancer drug Pebrilzo The Hindu Business Line05:20 14-Oct-26
    Biocon clears patent hurdle for breast cancer biosimilar Pebrilzo The Business Standard01:28 14-Oct-26
    Genentech Presents New Phase III One-Year Data for Vamikibart in Uveitic Macular Edema (Ume), a … Business Wire (Press Release)17:46 10-Oct-26
    In the last month
    FDA approves atezolizumab combination for stage III colon cancer with deficient DNA mismatch repair News-Medical.Net14:20 9-Oct-26
    “By Losing Weight, I Took Control of What Matters” Esquire13:35 9-Oct-26
    FDA Approves Genentech’s Tecentriq in Combination With a Fluoropyrimidine and Oxaliplatin for… Business Wire (Press Release)01:06 9-Oct-26
    South San Francisco's Alector Lands $100M Genentech Deal for Brain Drug Hoodline16:53 6-Oct-26
    Alector’s GCase ERT ‘Spurs’ $1.27B Genentech deal BioWorld16:45 5-Oct-26
    Alector Stock Rises 26% After Genentech Licensing Deal RTT News11:49 5-Oct-26
    Alector grants Genentech rights to GCase enzyme replacement therapy BioWorld10:48 5-Oct-26
    Genentech and Breastcancer.org Say It’s “About Damn Time” We Talk About What Happens When… Business Wire (Press Release)07:01 1-Oct-26
    Genentech's Giredestrant Posts Positive Phase 3 Data Ahead Of November, December FDA Dates RTT News04:23 1-Oct-26
    Genentech Presents New Data at Euretina, Highlighting Vabysmo’s Real-World Effectiveness and… Business Wire (Press Release)02:01 1-Oct-26
    Genentech’s Giredestrant Combination Significantly Improved Progression-Free Survival in… Business Wire (Press Release)01:05 1-Oct-26
    Genentech’s Fenebrutinib Is the First Btk Inhibitor to Receive U.S. FDA Filing Acceptance in… Business Wire (Press Release)01:03 30-Sep-26
    Hanmi to regain global rights to cancer drug belvarafenib from Genentech Korea Biomedical Review20:19 29-Sep-26
    China’s Rise as a Global Biopharma Innovation Hub: Navigating Trends, Opportunities, and Evolving Deal Structures JD Supra15:08 29-Sep-26
    Beyond Cellular Models: Longevica Capitalizes on World’s Largest In Vivo Longevity Study to… Business Wire (Press Release)10:52 29-Sep-26
    Governor Kotek Joins Genentech in Breaking Ground on New Facility in Hillsboro State of Oregon Government (Press Release)19:50 28-Sep-26
    Genentech Breaks Ground on $750 Million Manufacturing Expansion in Hillsboro, Oregon Business Wire (Press Release)18:03 28-Sep-26
    Roche and Earendil forge $1.5bn bispecific discovery deal Pharmaceutical Technology07:38 25-Sep-26
    Earendil’s AI platform lands $1.5B Genentech collaboration BioWorld17:18 24-Sep-26
    Earendil Labs Announces Research Collaboration with Genentech to Discover and Develop… PR Newswire (Press Release)07:04 24-Sep-26
    Positive Interim Data Shows Genentech’s Sefaxersen Significantly Reduces Proteinuria in People… Business Wire (Press Release)01:03 23-Sep-26
    A Passion for Helping the Youngest Patients UC San Diego News Center13:38 22-Sep-26
    Genentech Announces Positive Phase II Results for Dual GLP-1/Gip Receptor Agonist Enicepatide… Business Wire (Press Release)01:07 22-Sep-26
    Swiss pharma firm Roche opens new research centre in Boston Swiss Info08:31 19-Sep-26
    Roche Genentech Innovation Center opens in Boston focused on medical research with AI, data specialists Boston Herald17:57 17-Sep-26
    Genentech and Roche Announce Grand Opening of Boston R&D Innovation Center Business Wire (Press Release)14:33 17-Sep-26
    The CMO as impact driver: A conversation with Genentech CMO Zoë Lazarre The McKinsey Quarterly10:09 17-Sep-26
    Genentech’s Lunsumio-Based Regimen Significantly Improves Progression-Free Survival in… Business Wire (Press Release)01:03 17-Sep-26
    view more headlines
    16 Oct 11:13

    Genentech News

    NewsNow aims to be the world's most accurate and comprehensive aggregator of Genentech news, covering the latest share price, company announcements, product trials, biotechnology news and more from the best online publications. Every story from every site is brought to you automatically and continuously 24/7, within around 10 minutes of publication.
    Read more

    Biotech Top Stories

    Hll Lifecare launches eStore to expand direct-to-consumer reach The Times of India09:32
    Biomanufacturing spin-out from University of Sheffield secures £3m seed funding Insider Media01:12
    After Hikma: Vanda tests the limits of induced infringement JD Supra22:39
    On Wall Street, there’s trouble stirring for biotech STAT06:38
    Verastem’s KRAS inhibitor shows promise in pancreatic cancer STAT11:53

    Business Top Stories

    Tesla’s flying Roadster has Wall Street talking about SpaceX, not cars The Motley Fool21:36Tesla Tesla, Inc. Automotive
    Wall Street can’t stop sizing up a Tesla-SpaceX merger Investopedia18:05Tesla Tesla, Inc. Automotive
    Taiwan to fund $4 billion Texas complex for AI, Nvidia partners Insurance Journal12:39Nvidia IT Top Tech Brands
    Not Nvidia. Not TSMC. This equipment maker is the real bottleneck in AI chip production. The Motley Fool15:10Nvidia IT Top Tech Brands
    Fed Chair Kevin Warsh warns of AI 'shock,' pledges to contain inflation ABC News11:56Federal Reserve Central Banks US Economy
    Fed chair Warsh says price stability is key NewsMax08:24Federal Reserve Central Banks US Economy
    With demand set to outstrip supply until at least 2028, ASML stock is a buy The Motley Fool11:37ASML Microchips IT
    TSMC posts sixth straight quarter of record profit NewsMax08:20ASML Microchips IT
    AI credit worries send default insurance to record high Insurance Journal08:17Cloud Computing IT Internet
    Why is CoreWeave stock falling today? The Motley Fool13:08Cloud Computing IT Internet
    Publication filters

    Headline Density

    Sorry, no headlines or news topics were found. Please try different keywords.